[1]
Mohammed AL-Naqqash, M.A. 2016. Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues. Journal of the Faculty of Medicine Baghdad. 58, 4 (Jan. 2016), 307–311. DOI:https://doi.org/10.32007/jfacmedbagdad.584270.